Icon

PROTONIX (nda020987)- (EQ 40MG BASE,EQ 20MG BASE)

PANTOPRAZOLE SODIUM WYETH PHARMS
EQ 40MG BASE,EQ 20MG BASE
Yes No
2017-Jun-07 Expired
None None
None No
PROTONIX is a proton pump inhibitor (PPI) indicated for the following: • Short-Term Treatment of Erosive Esophagitis Associated with Gastroesophageal Reflux Disease (GERD) • Maintenance of Healing of Erosive Esophagitis • Pathological Hypersecretory Conditions Including Zollinger-Ellison (ZE) Syndrome
15 0 10
Total Other Developers None
Drugs with Suitability No
EQ 40MG BASE ** ** Up - 10
EQ 20MG BASE ** ** - - 7
NDA Sales Available Total Generic Sales Available
Yes 9
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ** ****** **** *** **. *****'* ************ ******* *********** ****** **. **, ** ****, ** **** & ** ****, ********** ******* *** ******, *******-********** ********,, *******-**********, ********* ******, ***** (***) ***
****** ******* ** *** ******* *******, ***. *********** **** * *** *, *******, ******* (**) *****, ****** ****** (***) ***
****** ******* ****** ******* *************** ******* *********** *********-******* *******, ******, ******-****, ****. *******, ******, ******* ******, ***** (***) ***
****** ******* ****** ******* *************** ******* *********** **** **. */*** ** ***, ***** *** ****-**, ****** *****, ****. *******, *******, ******* ******, ***** (***) ***
****** ********* ****** *** ********* ****** ******* *********** ****-***, ** **. ***/*, ***/*, ***/*, ***/* & ***/*, **** ** **** ***, *****, ***** ********** ****, *********, ********* ******, ************, ********* ******, ***** (***) ***
****** ****** **** *** * ****** *************** *** *********** *** ******** **, *********, *** **** (**) *****, ****** ****** (***) ***
****** ****** **** *** * ****** **** ******* *********** **** *, **. **.: ***, ***, *** & ***, ***** *********** ***, ********* *******, ************, ********* ******, ***** (***) ***
****** ****** ****** ****** *************** ******* ******* *********** ****** **.***, *** ** ***, **** ***** ********* *******-***** *******, ******* ******, *** *****, *********, ******* ******, ***** (***) ***
****** ******* ****** *** ************ ******* *** *********** ******** ********** ********** *, ******** ** *******, *****, ***** (***) ***
****** ******* ****** *** ************ ******* *** *********** ******* ** ********** *, ****** ** *******, ******** ** ******* *****, ***** (***) ***
****** ******* ****** ******* ****** ******* *********** ****-***, ******* *****, ****** **** ****, ***. ****** *******, ****** *****, *******, ******** ******* ******, ***** (***) ***
****** ******** ******** ***** ******* *********** **.**. ***/*, ***/*, ***, ***/*, ********** *******, ********-************* ******, *******-********** ********, ********* ******, ***** (***) ***
****** ** ****** **** *** **. *****'* ************ *********, *** *********** **** **** ******, **********, ********* (**) *****, ****** ****** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.